Trial Profile
A Pharmacoscintigraphic Clinical Study to Evaluate a Biphasic Release Sildenafil Formulation (With Immediate and Sustained Release Components) Compared to a Marketed Sildenafil Product in Fed and Fasted States
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary) ; Sildenafil
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors N4 Pharma
- 09 Jul 2018 Status changed from not yet recruiting to completed.
- 08 May 2018 New trial record